Skip to main content

Table 1 Patient characteristics

From: The impact of cardiac magnetic resonance viability assessment on the management of patients with ischaemic heart disease and left ventricular dysfunction

 

CABG (n=22)

PCI (n=30)

Medical therapy (n=56)

P value

Age (yrs)

67.0 ± 9.4

70.5 ± 8.9

69.5 ± 13.0

0.53

Gender (% m)

73

87

86

0.325

LVEF

28.3 ± 4.6

27.4 ± 5.3

25.8 ± 6.0

0.158

LVEDVi (mls/m2)

128.0 ± 29.9

139.8 ± 30.1

139.7 ± 29.5

0.259

LVESVi (mls/m2)

87.3 ± 25.9

101.5 ± 23.6

102.5 ± 25.9

0.049

No. of viable segments

13.1 ± 2.78

12.2 ± 3.0

10.5 ± 3.8

0.005

  1. LVEF- Left Ventricular Ejection Fraction
  2. LVEDVi- Left Ventricular End Diastolic Volume indexed to body surface area
  3. LVESVi- Left Ventricular End Systolic Volume indexed to body surface area